Zimmer Biomet (ZBH) Competitors $92.73 -2.62 (-2.74%) Closing price 03:59 PM EasternExtended Trading$92.73 +0.00 (+0.00%) As of 06:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ZBH vs. GEHC, PHG, SOLV, SNN, PEN, STVN, GKOS, NARI, INSP, and IRTCShould you be buying Zimmer Biomet stock or one of its competitors? The main competitors of Zimmer Biomet include GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Solventum (SOLV), Smith & Nephew (SNN), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), Inspire Medical Systems (INSP), and iRhythm Technologies (IRTC). These companies are all part of the "medical equipment" industry. Zimmer Biomet vs. GE HealthCare Technologies Koninklijke Philips Solventum Smith & Nephew Penumbra Stevanato Group Glaukos Inari Medical Inspire Medical Systems iRhythm Technologies Zimmer Biomet (NYSE:ZBH) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, earnings, community ranking, profitability, media sentiment, analyst recommendations, risk and institutional ownership. Is ZBH or GEHC more profitable? Zimmer Biomet has a net margin of 11.77% compared to GE HealthCare Technologies' net margin of 10.13%. GE HealthCare Technologies' return on equity of 25.74% beat Zimmer Biomet's return on equity.Company Net Margins Return on Equity Return on Assets Zimmer Biomet11.77% 12.99% 7.58% GE HealthCare Technologies 10.13%25.74%6.29% Which has more risk & volatility, ZBH or GEHC? Zimmer Biomet has a beta of 0.78, meaning that its share price is 22% less volatile than the S&P 500. Comparatively, GE HealthCare Technologies has a beta of 1.21, meaning that its share price is 21% more volatile than the S&P 500. Which has preferable earnings & valuation, ZBH or GEHC? GE HealthCare Technologies has higher revenue and earnings than Zimmer Biomet. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Zimmer Biomet, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZimmer Biomet$7.70B2.45$903.70M$4.5221.06GE HealthCare Technologies$19.80B1.66$1.99B$4.7515.13 Is ZBH or GEHC a better dividend stock? Zimmer Biomet pays an annual dividend of $0.96 per share and has a dividend yield of 1.0%. GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Zimmer Biomet pays out 21.2% of its earnings in the form of a dividend. GE HealthCare Technologies pays out 2.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. GE HealthCare Technologies has increased its dividend for 1 consecutive years. Does the MarketBeat Community believe in ZBH or GEHC? Zimmer Biomet received 879 more outperform votes than GE HealthCare Technologies when rated by MarketBeat users. Likewise, 66.91% of users gave Zimmer Biomet an outperform vote while only 62.00% of users gave GE HealthCare Technologies an outperform vote. CompanyUnderperformOutperformZimmer BiometOutperform Votes91066.91% Underperform Votes45033.09% GE HealthCare TechnologiesOutperform Votes3162.00% Underperform Votes1938.00% Do analysts prefer ZBH or GEHC? Zimmer Biomet currently has a consensus price target of $111.53, indicating a potential upside of 17.14%. GE HealthCare Technologies has a consensus price target of $88.27, indicating a potential upside of 22.86%. Given GE HealthCare Technologies' stronger consensus rating and higher probable upside, analysts clearly believe GE HealthCare Technologies is more favorable than Zimmer Biomet.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zimmer Biomet 2 Sell rating(s) 11 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.29GE HealthCare Technologies 0 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.83 Do insiders & institutionals hold more shares of ZBH or GEHC? 88.9% of Zimmer Biomet shares are owned by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are owned by institutional investors. 1.4% of Zimmer Biomet shares are owned by company insiders. Comparatively, 0.3% of GE HealthCare Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media prefer ZBH or GEHC? In the previous week, Zimmer Biomet had 4 more articles in the media than GE HealthCare Technologies. MarketBeat recorded 25 mentions for Zimmer Biomet and 21 mentions for GE HealthCare Technologies. GE HealthCare Technologies' average media sentiment score of 1.52 beat Zimmer Biomet's score of 1.29 indicating that GE HealthCare Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zimmer Biomet 19 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive GE HealthCare Technologies 20 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive SummaryGE HealthCare Technologies beats Zimmer Biomet on 11 of the 21 factors compared between the two stocks. Get Zimmer Biomet News Delivered to You Automatically Sign up to receive the latest news and ratings for ZBH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZBH vs. The Competition Export to ExcelMetricZimmer BiometSurgical appliances & supplies IndustryMedical SectorNYSE ExchangeMarket Cap$18.84B$9.70B$5.43B$19.70BDividend Yield0.99%1.61%5.22%3.84%P/E Ratio21.4021.4026.7935.13Price / Sales2.4566.68395.6736.36Price / Cash7.8519.6738.2517.51Price / Book1.525.226.864.78Net Income$903.70M$284.66M$3.22B$1.02B7 Day Performance-0.02%1.54%6.80%1.62%1 Month Performance-1.21%7.42%13.69%13.00%1 Year Performance-19.97%-19.10%18.25%5.59% Zimmer Biomet Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZBHZimmer Biomet4.8023 of 5 stars$92.73-2.7%$111.53+20.3%-20.1%$18.35B$7.70B20.8418,000Positive NewsHigh Trading VolumeGEHCGE HealthCare Technologies4.7813 of 5 stars$74.11+6.1%$88.27+19.1%-12.1%$33.93B$19.80B17.1250,000Positive NewsHigh Trading VolumePHGKoninklijke Philips2.4077 of 5 stars$25.04+2.0%N/A-12.5%$23.53B$17.98B-29.8078,200News CoverageAnalyst DowngradeSOLVSolventum2.012 of 5 stars$74.85+6.6%$79.00+5.5%+20.4%$12.95B$8.25B27.2222,000Positive NewsAnalyst UpgradeSNNSmith & Nephew2.2332 of 5 stars$28.43+0.3%$28.00-1.5%+12.9%$12.45B$5.81B13.1620,100News CoveragePENPenumbra4.7159 of 5 stars$296.98-0.1%$302.40+1.8%+39.5%$11.50B$1.24B873.473,900Positive NewsSTVNStevanato Group1.2475 of 5 stars€23.64-1.5%N/A+21.2%$7.16B$1.10B50.304,650Positive NewsGKOSGlaukos4.6427 of 5 stars$94.57+5.1%$134.67+42.4%-10.7%$5.40B$404.52M-32.95780News CoveragePositive NewsNARIInari Medical0.5635 of 5 stars$79.97flat$69.22-13.4%N/A$4.68B$493.63M-59.24800News CoverageINSPInspire Medical Systems4.6866 of 5 stars$156.54+3.5%$211.91+35.4%-3.4%$4.62B$840.11M90.49760Positive NewsGap UpIRTCiRhythm Technologies1.274 of 5 stars$137.80+0.1%$128.55-6.7%+52.5%$4.40B$618.59M-37.861,790Positive News Related Companies and Tools Related Companies GE HealthCare Technologies Competitors Koninklijke Philips Competitors Solventum Competitors Smith & Nephew Competitors Penumbra Competitors Stevanato Group Competitors Glaukos Competitors Inari Medical Competitors Inspire Medical Systems Competitors iRhythm Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ZBH) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zimmer Biomet Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zimmer Biomet With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
